Yahoo · Nov 13, 2026
QURE Stock Rallies 17.5% in a Month: What Should Investors Do Now?
uniQure shares rally 17.5% as FDA grants Priority Review to its Huntington's disease gene therapy, but it remains to be seen if clinical and regulatory progress can sustain momentum.

